Global Hemostatic Powders and Hemostatic Agents Supply, Demand and Key Producers, 2023-2029

Description

The global Hemostatic Powders and Hemostatic Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Hemostatic powders and hemostatic agents are medical products used to control bleeding or promote hemostasis (the process of stopping bleeding) in various clinical settings. These products are designed to aid in the management of bleeding in situations where conventional methods such as pressure, sutures, or cauterization may be insufficient or impractical.

This report studies the global Hemostatic Powders and Hemostatic Agents demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hemostatic Powders and Hemostatic Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hemostatic Powders and Hemostatic Agents that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hemostatic Powders and Hemostatic Agents total market, 2018-2029, (USD Million)
Global Hemostatic Powders and Hemostatic Agents total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Hemostatic Powders and Hemostatic Agents total market, key domestic companies and share, (USD Million)
Global Hemostatic Powders and Hemostatic Agents revenue by player and market share 2018-2023, (USD Million)
Global Hemostatic Powders and Hemostatic Agents total market by Type, CAGR, 2018-2029, (USD Million)
Global Hemostatic Powders and Hemostatic Agents total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Hemostatic Powders and Hemostatic Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Medline Industries, Baxter, Pfizer, Zimmer Biomet, McKesson, Integra Life Sciences, Medtronic and CryoLife, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hemostatic Powders and Hemostatic Agents market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hemostatic Powders and Hemostatic Agents Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hemostatic Powders and Hemostatic Agents Market, Segmentation by Type
    Microfibrous Collagen
    Chitosan

Global Hemostatic Powders and Hemostatic Agents Market, Segmentation by Application
    Home
    Clinic
    Hospital

Companies Profiled:
    BD
    Medline Industries
    Baxter
    Pfizer
    Zimmer Biomet
    McKesson
    Integra Life Sciences
    Medtronic
    CryoLife
    CSL Behring
    Ethicon
    B Braun Melsungen
    Gelita Medical
    Smith & Nephew
    Teleflex
    Novartis
    Anika Therapeutics
    Advanced Medical Solutions

Key Questions Answered
1. How big is the global Hemostatic Powders and Hemostatic Agents market?
2. What is the demand of the global Hemostatic Powders and Hemostatic Agents market?
3. What is the year over year growth of the global Hemostatic Powders and Hemostatic Agents market?
4. What is the total value of the global Hemostatic Powders and Hemostatic Agents market?
5. Who are the major players in the global Hemostatic Powders and Hemostatic Agents market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Hemostatic Powders and Hemostatic Agents Introduction
    1.2 World Hemostatic Powders and Hemostatic Agents Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Hemostatic Powders and Hemostatic Agents Total Market by Region (by Headquarter Location)
        1.3.1 World Hemostatic Powders and Hemostatic Agents Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
        1.3.3 China Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
        1.3.4 Europe Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
        1.3.5 Japan Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
        1.3.6 South Korea Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
        1.3.7 ASEAN Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
        1.3.8 India Hemostatic Powders and Hemostatic Agents Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hemostatic Powders and Hemostatic Agents Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hemostatic Powders and Hemostatic Agents Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)
    2.2 World Hemostatic Powders and Hemostatic Agents Consumption Value by Region
        2.2.1 World Hemostatic Powders and Hemostatic Agents Consumption Value by Region (2018-2023)
        2.2.2 World Hemostatic Powders and Hemostatic Agents Consumption Value Forecast by Region (2024-2029)
    2.3 United States Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)
    2.4 China Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)
    2.5 Europe Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)
    2.6 Japan Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)
    2.7 South Korea Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)
    2.8 ASEAN Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)
    2.9 India Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029)

3 World Hemostatic Powders and Hemostatic Agents Companies Competitive Analysis
    3.1 World Hemostatic Powders and Hemostatic Agents Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Hemostatic Powders and Hemostatic Agents Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Hemostatic Powders and Hemostatic Agents in 2022
        3.2.3 Global Concentration Ratios (CR8) for Hemostatic Powders and Hemostatic Agents in 2022
    3.3 Hemostatic Powders and Hemostatic Agents Company Evaluation Quadrant
    3.4 Hemostatic Powders and Hemostatic Agents Market: Overall Company Footprint Analysis
        3.4.1 Hemostatic Powders and Hemostatic Agents Market: Region Footprint
        3.4.2 Hemostatic Powders and Hemostatic Agents Market: Company Product Type Footprint
        3.4.3 Hemostatic Powders and Hemostatic Agents Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Hemostatic Powders and Hemostatic Agents Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Hemostatic Powders and Hemostatic Agents Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Hemostatic Powders and Hemostatic Agents Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Hemostatic Powders and Hemostatic Agents Consumption Value Comparison
        4.2.1 United States VS China: Hemostatic Powders and Hemostatic Agents Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Hemostatic Powders and Hemostatic Agents Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Hemostatic Powders and Hemostatic Agents Companies and Market Share, 2018-2023
        4.3.1 United States Based Hemostatic Powders and Hemostatic Agents Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Hemostatic Powders and Hemostatic Agents Revenue, (2018-2023)
    4.4 China Based Companies Hemostatic Powders and Hemostatic Agents Revenue and Market Share, 2018-2023
        4.4.1 China Based Hemostatic Powders and Hemostatic Agents Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Hemostatic Powders and Hemostatic Agents Revenue, (2018-2023)
    4.5 Rest of World Based Hemostatic Powders and Hemostatic Agents Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Hemostatic Powders and Hemostatic Agents Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Hemostatic Powders and Hemostatic Agents Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Hemostatic Powders and Hemostatic Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Microfibrous Collagen
        5.2.2 Chitosan
    5.3 Market Segment by Type
        5.3.1 World Hemostatic Powders and Hemostatic Agents Market Size by Type (2018-2023)
        5.3.2 World Hemostatic Powders and Hemostatic Agents Market Size by Type (2024-2029)
        5.3.3 World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Hemostatic Powders and Hemostatic Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Home
        6.2.2 Clinic
        6.2.3 Hospital
    6.3 Market Segment by Application
        6.3.1 World Hemostatic Powders and Hemostatic Agents Market Size by Application (2018-2023)
        6.3.2 World Hemostatic Powders and Hemostatic Agents Market Size by Application (2024-2029)
        6.3.3 World Hemostatic Powders and Hemostatic Agents Market Size by Application (2018-2029)

7 Company Profiles
    7.1 BD
        7.1.1 BD Details
        7.1.2 BD Major Business
        7.1.3 BD Hemostatic Powders and Hemostatic Agents Product and Services
        7.1.4 BD Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 BD Recent Developments/Updates
        7.1.6 BD Competitive Strengths & Weaknesses
    7.2 Medline Industries
        7.2.1 Medline Industries Details
        7.2.2 Medline Industries Major Business
        7.2.3 Medline Industries Hemostatic Powders and Hemostatic Agents Product and Services
        7.2.4 Medline Industries Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Medline Industries Recent Developments/Updates
        7.2.6 Medline Industries Competitive Strengths & Weaknesses
    7.3 Baxter
        7.3.1 Baxter Details
        7.3.2 Baxter Major Business
        7.3.3 Baxter Hemostatic Powders and Hemostatic Agents Product and Services
        7.3.4 Baxter Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Baxter Recent Developments/Updates
        7.3.6 Baxter Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Hemostatic Powders and Hemostatic Agents Product and Services
        7.4.4 Pfizer Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 Zimmer Biomet
        7.5.1 Zimmer Biomet Details
        7.5.2 Zimmer Biomet Major Business
        7.5.3 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Product and Services
        7.5.4 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Zimmer Biomet Recent Developments/Updates
        7.5.6 Zimmer Biomet Competitive Strengths & Weaknesses
    7.6 McKesson
        7.6.1 McKesson Details
        7.6.2 McKesson Major Business
        7.6.3 McKesson Hemostatic Powders and Hemostatic Agents Product and Services
        7.6.4 McKesson Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 McKesson Recent Developments/Updates
        7.6.6 McKesson Competitive Strengths & Weaknesses
    7.7 Integra Life Sciences
        7.7.1 Integra Life Sciences Details
        7.7.2 Integra Life Sciences Major Business
        7.7.3 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Product and Services
        7.7.4 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Integra Life Sciences Recent Developments/Updates
        7.7.6 Integra Life Sciences Competitive Strengths & Weaknesses
    7.8 Medtronic
        7.8.1 Medtronic Details
        7.8.2 Medtronic Major Business
        7.8.3 Medtronic Hemostatic Powders and Hemostatic Agents Product and Services
        7.8.4 Medtronic Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Medtronic Recent Developments/Updates
        7.8.6 Medtronic Competitive Strengths & Weaknesses
    7.9 CryoLife
        7.9.1 CryoLife Details
        7.9.2 CryoLife Major Business
        7.9.3 CryoLife Hemostatic Powders and Hemostatic Agents Product and Services
        7.9.4 CryoLife Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 CryoLife Recent Developments/Updates
        7.9.6 CryoLife Competitive Strengths & Weaknesses
    7.10 CSL Behring
        7.10.1 CSL Behring Details
        7.10.2 CSL Behring Major Business
        7.10.3 CSL Behring Hemostatic Powders and Hemostatic Agents Product and Services
        7.10.4 CSL Behring Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 CSL Behring Recent Developments/Updates
        7.10.6 CSL Behring Competitive Strengths & Weaknesses
    7.11 Ethicon
        7.11.1 Ethicon Details
        7.11.2 Ethicon Major Business
        7.11.3 Ethicon Hemostatic Powders and Hemostatic Agents Product and Services
        7.11.4 Ethicon Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Ethicon Recent Developments/Updates
        7.11.6 Ethicon Competitive Strengths & Weaknesses
    7.12 B Braun Melsungen
        7.12.1 B Braun Melsungen Details
        7.12.2 B Braun Melsungen Major Business
        7.12.3 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Product and Services
        7.12.4 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 B Braun Melsungen Recent Developments/Updates
        7.12.6 B Braun Melsungen Competitive Strengths & Weaknesses
    7.13 Gelita Medical
        7.13.1 Gelita Medical Details
        7.13.2 Gelita Medical Major Business
        7.13.3 Gelita Medical Hemostatic Powders and Hemostatic Agents Product and Services
        7.13.4 Gelita Medical Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Gelita Medical Recent Developments/Updates
        7.13.6 Gelita Medical Competitive Strengths & Weaknesses
    7.14 Smith & Nephew
        7.14.1 Smith & Nephew Details
        7.14.2 Smith & Nephew Major Business
        7.14.3 Smith & Nephew Hemostatic Powders and Hemostatic Agents Product and Services
        7.14.4 Smith & Nephew Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Smith & Nephew Recent Developments/Updates
        7.14.6 Smith & Nephew Competitive Strengths & Weaknesses
    7.15 Teleflex
        7.15.1 Teleflex Details
        7.15.2 Teleflex Major Business
        7.15.3 Teleflex Hemostatic Powders and Hemostatic Agents Product and Services
        7.15.4 Teleflex Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Teleflex Recent Developments/Updates
        7.15.6 Teleflex Competitive Strengths & Weaknesses
    7.16 Novartis
        7.16.1 Novartis Details
        7.16.2 Novartis Major Business
        7.16.3 Novartis Hemostatic Powders and Hemostatic Agents Product and Services
        7.16.4 Novartis Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Novartis Recent Developments/Updates
        7.16.6 Novartis Competitive Strengths & Weaknesses
    7.17 Anika Therapeutics
        7.17.1 Anika Therapeutics Details
        7.17.2 Anika Therapeutics Major Business
        7.17.3 Anika Therapeutics Hemostatic Powders and Hemostatic Agents Product and Services
        7.17.4 Anika Therapeutics Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Anika Therapeutics Recent Developments/Updates
        7.17.6 Anika Therapeutics Competitive Strengths & Weaknesses
    7.18 Advanced Medical Solutions
        7.18.1 Advanced Medical Solutions Details
        7.18.2 Advanced Medical Solutions Major Business
        7.18.3 Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Product and Services
        7.18.4 Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Advanced Medical Solutions Recent Developments/Updates
        7.18.6 Advanced Medical Solutions Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hemostatic Powders and Hemostatic Agents Industry Chain
    8.2 Hemostatic Powders and Hemostatic Agents Upstream Analysis
    8.3 Hemostatic Powders and Hemostatic Agents Midstream Analysis
    8.4 Hemostatic Powders and Hemostatic Agents Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hemostatic Powders and Hemostatic Agents Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Hemostatic Powders and Hemostatic Agents Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Hemostatic Powders and Hemostatic Agents Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Hemostatic Powders and Hemostatic Agents Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Hemostatic Powders and Hemostatic Agents Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Hemostatic Powders and Hemostatic Agents Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Hemostatic Powders and Hemostatic Agents Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Hemostatic Powders and Hemostatic Agents Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Hemostatic Powders and Hemostatic Agents Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Hemostatic Powders and Hemostatic Agents Players in 2022
    Table 12. World Hemostatic Powders and Hemostatic Agents Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Hemostatic Powders and Hemostatic Agents Company Evaluation Quadrant
    Table 14. Head Office of Key Hemostatic Powders and Hemostatic Agents Player
    Table 15. Hemostatic Powders and Hemostatic Agents Market: Company Product Type Footprint
    Table 16. Hemostatic Powders and Hemostatic Agents Market: Company Product Application Footprint
    Table 17. Hemostatic Powders and Hemostatic Agents Mergers & Acquisitions Activity
    Table 18. United States VS China Hemostatic Powders and Hemostatic Agents Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Hemostatic Powders and Hemostatic Agents Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Hemostatic Powders and Hemostatic Agents Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Hemostatic Powders and Hemostatic Agents Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Hemostatic Powders and Hemostatic Agents Revenue Market Share (2018-2023)
    Table 23. China Based Hemostatic Powders and Hemostatic Agents Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Hemostatic Powders and Hemostatic Agents Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Hemostatic Powders and Hemostatic Agents Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Hemostatic Powders and Hemostatic Agents Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Hemostatic Powders and Hemostatic Agents Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Hemostatic Powders and Hemostatic Agents Revenue Market Share (2018-2023)
    Table 29. World Hemostatic Powders and Hemostatic Agents Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Hemostatic Powders and Hemostatic Agents Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Hemostatic Powders and Hemostatic Agents Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Hemostatic Powders and Hemostatic Agents Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Hemostatic Powders and Hemostatic Agents Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Hemostatic Powders and Hemostatic Agents Market Size by Application (2024-2029) & (USD Million)
    Table 35. BD Basic Information, Area Served and Competitors
    Table 36. BD Major Business
    Table 37. BD Hemostatic Powders and Hemostatic Agents Product and Services
    Table 38. BD Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. BD Recent Developments/Updates
    Table 40. BD Competitive Strengths & Weaknesses
    Table 41. Medline Industries Basic Information, Area Served and Competitors
    Table 42. Medline Industries Major Business
    Table 43. Medline Industries Hemostatic Powders and Hemostatic Agents Product and Services
    Table 44. Medline Industries Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Medline Industries Recent Developments/Updates
    Table 46. Medline Industries Competitive Strengths & Weaknesses
    Table 47. Baxter Basic Information, Area Served and Competitors
    Table 48. Baxter Major Business
    Table 49. Baxter Hemostatic Powders and Hemostatic Agents Product and Services
    Table 50. Baxter Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Baxter Recent Developments/Updates
    Table 52. Baxter Competitive Strengths & Weaknesses
    Table 53. Pfizer Basic Information, Area Served and Competitors
    Table 54. Pfizer Major Business
    Table 55. Pfizer Hemostatic Powders and Hemostatic Agents Product and Services
    Table 56. Pfizer Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Pfizer Recent Developments/Updates
    Table 58. Pfizer Competitive Strengths & Weaknesses
    Table 59. Zimmer Biomet Basic Information, Area Served and Competitors
    Table 60. Zimmer Biomet Major Business
    Table 61. Zimmer Biomet Hemostatic Powders and Hemostatic Agents Product and Services
    Table 62. Zimmer Biomet Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Zimmer Biomet Recent Developments/Updates
    Table 64. Zimmer Biomet Competitive Strengths & Weaknesses
    Table 65. McKesson Basic Information, Area Served and Competitors
    Table 66. McKesson Major Business
    Table 67. McKesson Hemostatic Powders and Hemostatic Agents Product and Services
    Table 68. McKesson Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. McKesson Recent Developments/Updates
    Table 70. McKesson Competitive Strengths & Weaknesses
    Table 71. Integra Life Sciences Basic Information, Area Served and Competitors
    Table 72. Integra Life Sciences Major Business
    Table 73. Integra Life Sciences Hemostatic Powders and Hemostatic Agents Product and Services
    Table 74. Integra Life Sciences Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Integra Life Sciences Recent Developments/Updates
    Table 76. Integra Life Sciences Competitive Strengths & Weaknesses
    Table 77. Medtronic Basic Information, Area Served and Competitors
    Table 78. Medtronic Major Business
    Table 79. Medtronic Hemostatic Powders and Hemostatic Agents Product and Services
    Table 80. Medtronic Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Medtronic Recent Developments/Updates
    Table 82. Medtronic Competitive Strengths & Weaknesses
    Table 83. CryoLife Basic Information, Area Served and Competitors
    Table 84. CryoLife Major Business
    Table 85. CryoLife Hemostatic Powders and Hemostatic Agents Product and Services
    Table 86. CryoLife Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. CryoLife Recent Developments/Updates
    Table 88. CryoLife Competitive Strengths & Weaknesses
    Table 89. CSL Behring Basic Information, Area Served and Competitors
    Table 90. CSL Behring Major Business
    Table 91. CSL Behring Hemostatic Powders and Hemostatic Agents Product and Services
    Table 92. CSL Behring Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. CSL Behring Recent Developments/Updates
    Table 94. CSL Behring Competitive Strengths & Weaknesses
    Table 95. Ethicon Basic Information, Area Served and Competitors
    Table 96. Ethicon Major Business
    Table 97. Ethicon Hemostatic Powders and Hemostatic Agents Product and Services
    Table 98. Ethicon Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Ethicon Recent Developments/Updates
    Table 100. Ethicon Competitive Strengths & Weaknesses
    Table 101. B Braun Melsungen Basic Information, Area Served and Competitors
    Table 102. B Braun Melsungen Major Business
    Table 103. B Braun Melsungen Hemostatic Powders and Hemostatic Agents Product and Services
    Table 104. B Braun Melsungen Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. B Braun Melsungen Recent Developments/Updates
    Table 106. B Braun Melsungen Competitive Strengths & Weaknesses
    Table 107. Gelita Medical Basic Information, Area Served and Competitors
    Table 108. Gelita Medical Major Business
    Table 109. Gelita Medical Hemostatic Powders and Hemostatic Agents Product and Services
    Table 110. Gelita Medical Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Gelita Medical Recent Developments/Updates
    Table 112. Gelita Medical Competitive Strengths & Weaknesses
    Table 113. Smith & Nephew Basic Information, Area Served and Competitors
    Table 114. Smith & Nephew Major Business
    Table 115. Smith & Nephew Hemostatic Powders and Hemostatic Agents Product and Services
    Table 116. Smith & Nephew Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Smith & Nephew Recent Developments/Updates
    Table 118. Smith & Nephew Competitive Strengths & Weaknesses
    Table 119. Teleflex Basic Information, Area Served and Competitors
    Table 120. Teleflex Major Business
    Table 121. Teleflex Hemostatic Powders and Hemostatic Agents Product and Services
    Table 122. Teleflex Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Teleflex Recent Developments/Updates
    Table 124. Teleflex Competitive Strengths & Weaknesses
    Table 125. Novartis Basic Information, Area Served and Competitors
    Table 126. Novartis Major Business
    Table 127. Novartis Hemostatic Powders and Hemostatic Agents Product and Services
    Table 128. Novartis Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Novartis Recent Developments/Updates
    Table 130. Novartis Competitive Strengths & Weaknesses
    Table 131. Anika Therapeutics Basic Information, Area Served and Competitors
    Table 132. Anika Therapeutics Major Business
    Table 133. Anika Therapeutics Hemostatic Powders and Hemostatic Agents Product and Services
    Table 134. Anika Therapeutics Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Anika Therapeutics Recent Developments/Updates
    Table 136. Advanced Medical Solutions Basic Information, Area Served and Competitors
    Table 137. Advanced Medical Solutions Major Business
    Table 138. Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Product and Services
    Table 139. Advanced Medical Solutions Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 140. Global Key Players of Hemostatic Powders and Hemostatic Agents Upstream (Raw Materials)
    Table 141. Hemostatic Powders and Hemostatic Agents Typical Customers
List of Figure
    Figure 1. Hemostatic Powders and Hemostatic Agents Picture
    Figure 2. World Hemostatic Powders and Hemostatic Agents Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Hemostatic Powders and Hemostatic Agents Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Hemostatic Powders and Hemostatic Agents Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Hemostatic Powders and Hemostatic Agents Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Hemostatic Powders and Hemostatic Agents Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Hemostatic Powders and Hemostatic Agents Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Hemostatic Powders and Hemostatic Agents Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Hemostatic Powders and Hemostatic Agents Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Hemostatic Powders and Hemostatic Agents Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Hemostatic Powders and Hemostatic Agents Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Hemostatic Powders and Hemostatic Agents Revenue (2018-2029) & (USD Million)
    Figure 13. Hemostatic Powders and Hemostatic Agents Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Hemostatic Powders and Hemostatic Agents Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Hemostatic Powders and Hemostatic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Hemostatic Powders and Hemostatic Agents by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Hemostatic Powders and Hemostatic Agents Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Hemostatic Powders and Hemostatic Agents Markets in 2022
    Figure 27. United States VS China: Hemostatic Powders and Hemostatic Agents Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Hemostatic Powders and Hemostatic Agents Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Hemostatic Powders and Hemostatic Agents Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Type in 2022
    Figure 31. Microfibrous Collagen
    Figure 32. Chitosan
    Figure 33. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Type (2018-2029)
    Figure 34. World Hemostatic Powders and Hemostatic Agents Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Application in 2022
    Figure 36. Home
    Figure 37. Clinic
    Figure 38. Hospital
    Figure 39. Hemostatic Powders and Hemostatic Agents Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Companies Mentioned

BD
Medline Industries
Baxter
Pfizer
Zimmer Biomet
McKesson
Integra Life Sciences
Medtronic
CryoLife
CSL Behring
Ethicon
B Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex
Novartis
Anika Therapeutics
Advanced Medical Solutions